project id: TCGA-STAD; case submitter id: TCGA-IN-A7NU; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.91; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.18; rna integrity number: 7.5; age at index: 69; days to birth: -25515; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1944; age at diagnosis: 25515; ajcc pathologic m: M0; ajcc pathologic n: N3; ajcc pathologic stage: Stage IIIB; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 356.0; icd 10 code: C16.0; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cardia, NOS; synchronous malignancy: No; tissue or organ of origin: Cardia, NOS; tumor grade: Not Reported; year of diagnosis: 2013; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 100; initial weight: 240.0; sample id: 5eb49910-8199-43e3-a221-e7399ab23c08; sample submitter id: TCGA-IN-A7NU-01A; portion id: a51d6303-5732-4c47-b277-38ae36d09123; portion submitter id: TCGA-IN-A7NU-01A-22; slide id: a02dbb97-f71a-4849-a354-1100469a8540; slide submitter id: TCGA-IN-A7NU-01A-02-TSB; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 10.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0; section location: TOP;